RxDoctor Payments Data

Christopher Chittum, MD

Neurological Surgery · Spartanburg, SCNPI 1548286412

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (51.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Vy Spine LLC at 50.5% of the total. 2025 is the largest year on record at $14,545, more than ten times the $1,253 reported in 2019.

$27,850in general payments, 2019–2025

Across 54 payments — averaging $515.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vy Spine LLC$14K
  • Alphatec Spine, Inc$11K
  • Orthofix Medical, Inc.$972
  • Spineology Inc.$876
  • Abbott$648
  • Globus Medical$233
  • plus $548 from 8 others
$333,760in research payments, 2019–2025

Across 4 payments — averaging $83,440 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Allied Spinal Industries$334K

What the payments were for

  • Royalty or licence$14,29051%
  • Travel & lodging$11,63342%
  • Food & beverage$1,9277%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,850 in reported general payments places this provider in the 85th percentile of 114 neurological surgery providers in South Carolina.

See all neurological surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$333,020
Medicare patients
673
Services billed
4,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen11$1,616
Gabapentin61$535
Tizanidine Hcl24$417
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$367
Cyclobenzaprine Hcl34$295
Oxycodone Hcl36$275
Methocarbamol23$260
Meloxicam55$171
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$151
Pregabalin11$133
Tramadol Hcl30$100
Methylprednisolone17$78

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →